A Novel Class of Cationic and Non-Peptidic Small Molecules as Hits for the Development of Antimicrobial Agents

被引:7
作者
Jimenez, Aranza [1 ,4 ]
Garcia, Pablo [2 ]
de la Puente, Sofia [1 ]
Madrona, Andres [1 ,5 ]
Jose Camarasa, Maria [1 ]
Perez-Perez, Maria-Jesus [1 ]
Quintela, Jose-Carlos [3 ]
Garcia-del Portillo, Francisco [2 ]
San-Felix, Ana [1 ]
机构
[1] CSIC, Inst Quim Med, Juan Cierva 3, E-28006 Madrid, Spain
[2] CSIC, CNB, Lab Patogenos Bacterianos Intracelulares, Darwin 3, Madrid 28049, Spain
[3] Natac Biotech SL, Parque Cient Madrid,Campus Cantoblanco, Madrid 28049, Spain
[4] Agencia Espanola Medicamentos & Prod Sanitario, Campezo 1,Edificio 8, Madrid 28022, Spain
[5] Novartis Farmaceut SA, Gran Via Corts Catalanes 764, Barcelona 08013, Spain
来源
MOLECULES | 2018年 / 23卷 / 07期
关键词
antimicrobial agents; antibiotic resistance; antimicrobial peptides; HOST-DEFENSE PEPTIDES; UNITED-STATES; RESISTANCE; MECHANISMS;
D O I
10.3390/molecules23071513
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cationic and non-peptide small molecules containing a total of six positive charges arranged on one side and a long aliphatic tail on the other have been synthesized and tested against Gram-positive and Gram-negative bacteria. The positive charges have been contributed by two aminophenol residues. These molecules have showed remarkable antimicrobial activity against Gram-positive bacteria including multidrug-resistant strains. Our structure-activity relationship studies demonstrated the importance of the length and flexibility of the hydrophobic tail for the antimicrobial activity. Importantly, these compounds are non-toxic to eukaryotic cells at the concentration affecting growth in bacteria, reflecting an acceptable margin of safety. The small size and easy synthetic accessibility of our molecules can be of interest for the further development of novel antimicrobials against Gram-positive bacterial pathogens, including multidrug-resistant strains.
引用
收藏
页数:18
相关论文
共 33 条
  • [21] Discovery of a novel class of small-molecule antibacterial agents against Staphylococcus aureus
    Kreutzer, David
    Gehrmann, Robin
    Kincses, Annamaria
    Szemeredi, Nikoletta
    Spengler, Gabriella
    Molnar, Josef
    Hilgeroth, Andreas
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (05) : 299 - 306
  • [22] The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization
    Ihmaid, Saleh
    Ahmed, Hany E. A.
    Zayed, Mohamed F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [23] Characterization of two novel small molecules targeting melanocyte development in zebrafish embryogenesis
    Chen, Lu
    Ren, Xi
    Liang, Fang
    Li, Song
    Zhong, Hanbing
    Lin, Shuo
    PIGMENT CELL & MELANOMA RESEARCH, 2012, 25 (04) : 446 - 453
  • [24] Epothilones in Development for Non-Small-Cell Lung Cancer: Novel Anti-Tubulin Agents With the Potential to Overcome Taxane Resistance
    Edelman, Martin J.
    Shvartsbeyn, Marianna
    CLINICAL LUNG CANCER, 2012, 13 (03) : 171 - 180
  • [25] Novel ionic polymers encompassing di-cationic pyridinium hydrazones and aromatic ester as potent antimicrobial agents against resistant bacteria
    Al-Sodies, Salsabeel
    Asiri, Abdullah M.
    Thabet, Mohammed A.
    Aouad, Mohamed Reda
    Rezki, Nadjet
    Hussein, Mahmoud A.
    POLYMER, 2024, 308
  • [26] Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
    Rolfo, Christian
    Fanale, Daniele
    Hong, David S.
    Tsimberidou, Apostolia M.
    Piha-Paul, Sarina A.
    Pauwels, Patrick
    Van Meerbeeck, Jan P.
    Caruso, Stefano
    Bazan, Viviana
    Cicero, Giuseppe
    Russo, Antonio
    Giovannetti, Elisa
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (05) : 475 - 485
  • [27] Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class
    Marks, Jennifer A.
    Wilgucki, Molly
    Liu, Stephen V.
    Reuss, Joshua E.
    CURRENT ONCOLOGY REPORTS, 2022, 24 (12) : 1829 - 1841
  • [28] Novel chalcone-derived pyrazoles as potential therapeutic agents for the treatment of non-small cell lung cancer
    Maciejewska, Natalia
    Olszewski, Mateusz
    Jurasz, Jakub
    Serocki, Marcin
    Dzierzynska, Maria
    Cekala, Katarzyna
    Wieczerzak, Ewa
    Baginski, Maciej
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer
    Singh, Pankaj Kumar
    Silakari, Om
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (05) : 469 - 483
  • [30] Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer
    Liu, Xuesha
    Pu, Wenchen
    He, Huaiyu
    Fan, Xin
    Zheng, Yuanyuan
    Zhou, Jian-Kang
    Ma, Rui
    He, Juan
    Zheng, Yuzhu
    Wu, Ke
    Zhao, Yun
    Yang, Sheng-Yong
    Wang, Chun
    Wei, Yu-Quan
    Wei, Xia-Wei
    Peng, Yong
    CANCER LETTERS, 2019, 458 : 76 - 85